Zileuton and Exhaled Nitric Oxide in Asthmatics

PHASE4CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 30, 2005

Study Completion Date

November 30, 2007

Conditions

Asthma

Interventions

DRUG

zileuton

zileuton (Zyflo) 600mg qid for 2hr and for 30 days

Trial Locations (1)

Arthur F Gelb Medical Corporation, Lakewood

All Listed Sponsors

lead

Gelb, Arthur F., M.D.

INDIV

NCT00575861 - Zileuton and Exhaled Nitric Oxide in Asthmatics | Biotech Hunter | Biotech Hunter